Tailored Regulatory and Access Strategies to Drive Cell and Gene Therapy Innovation and Value for Clinical Developers

The clinical development of advanced therapies often proceeds without a robust understanding of the rapidly changing regulatory and commercial environment.As more cell and gene therapies come to market and indications for the recently approved therapies are likely to expand, reimbursement challenges will also increase.This panel discussion focuses on regulatory and access strategies to ensure that your clinical development plans are aligned with your commercial goals aa well as the regulatory and market realities.